Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Tribbles pseudokinase-3 (TRIB3) has been proposed to act as an inhibitor of AKT although the precise molecular basis of this activity and whether the loss of TRIB3 contributes to cancer initiation and progression remain to be clarified. In this study, by using a wide array of in vitro and in vivo approaches, including a Trib3 knockout mouse, we demonstrate that TRIB3 has a tumor-suppressing role. We also find that the mechanism by which TRIB3 loss enhances tumorigenesis relies on the dysregulation of the phosphorylation of AKT by the mTORC2 complex, which leads to an enhanced phosphorylation of AKT on Ser473 and the subsequent hyperphosphorylation and inactivation of the transcription factor FOXO3. These observations support the notion that loss of TRIB3 is associated with a more aggressive phenotype in various types of tumors by enhancing the activity of the mTORC2/AKT/FOXO axis.

Citation

M Salazar, M Lorente, E García-Taboada, E Pérez Gómez, D Dávila, P Zúñiga-García, J María Flores, A Rodríguez, Z Hegedus, D Mosén-Ansorena, A M Aransay, S Hernández-Tiedra, I López-Valero, M Quintanilla, C Sánchez, J L Iovanna, N Dusetti, M Guzmán, S E Francis, A Carracedo, E Kiss-Toth, G Velasco. Loss of Tribbles pseudokinase-3 promotes Akt-driven tumorigenesis via FOXO inactivation. Cell death and differentiation. 2015 Jan;22(1):131-44

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 25168244

View Full Text